A Phase 2, Multicenter, Randomized, Parallel Study to Evaluate the Efficacy and Safety of Two Doses of ENN0403 in Subjects with Diabetic Macular Edema (DME)
Latest Information Update: 02 Dec 2024
Price :
$35 *
At a glance
- Drugs ENN-0403 (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors EnnovaBio
- 02 Dec 2024 New trial record